GlassScriptPhysician profile
Lori A Johnson
NPI 1881789949
$919.59
in general payments reported to CMS, 2019-2025
16 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $49.93 · 2023: $138 · 2024: $254 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $140.48 | 2021 | |
| Glaxosmithkline, LLC. | $122.42 | 2024-2025 | Shingrix, Arexvy, Bexsero |
| Idorsia Pharmaceuticals US INC | $117.79 | 2023 | Quviviq |
| Mauna Kea Technologies, INC. | $77.22 | 2022-2025 | |
| Lilly USA, LLC | $71.13 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $59.91 | 2022-2025 | Wegovy |
| Sanofi Pasteur INC. | $54.27 | 2024-2025 | |
| Abbvie INC. | $53.68 | 2024-2025 | |
| Radius Health, INC. | $52.34 | 2024-2025 | Tymlos |
| Pfizer INC. | $40.15 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $33.18 | 2024 | Voquezna |
| Viatris Specialty LLC | $23.97 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $23.36 | 2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Novartis Pharmaceuticals Corporation | $20.42 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.65 | 2024 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.